Products
  1. Home
  2. Products
  3. Inhibitors & Activators for IBD Research
Products
Inquiry

* Please note that all of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.

Antitumor agent-73

Cat. No.: IBDI-432371

Antitumor agent-73 is a Diosgenin (HY-N0177) derivative, which inhibits STAT3 signaling and activates Pdia3/ERp57 exogenously. Antitumor agent-73 shows potent anti-tumor activity against various cancer cell lines, 7.9-341.7-fold stronger than Diosgenin.

Size (Solid):

Product Details

Target STAT
Molecular Weight 858.06
SMILES C[[email protected]]1[[email protected]]2[[email protected]](CC3C4CC=C5C[[email protected]@H](OC(CCCC[P+](C6CCCCC6)(C7CCCCC7)C8CCCCC8)=O)CC[[email protected]]5(C)C4CC[[email protected]@]32C)O[[email protected]]19CC[[email protected]](CO9)C.[Br-]

Storage & Handling

Shipping Room temperature in continental US. May vary elsewhere.
Storage Please store the product under the recommended conditions in the Certificate of Analysis.
Regulatory Status This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use.
! For research use only, not intended for any clinical use.
Copyright © Ace Therapeutics. All rights reserved.